Alpha Healthcare Acquisition Corp. III (ALPA) Closes Carmell Deal
by Nicholas Alan Clayton on 2023-07-14 at 3:43pm

Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) announced this afternoon that it has closed its combination with drug developer Carmell having secured shareholder approval at a special meeting on July 11.

The combined company’s shares and warrants are expected to begin trading on the Nasdaq under the symbols “CTCX” and “CTCXW” on July 17.

The SPAC also divulged in an 8-K that it had better-than-average redemptions in the end with 81.5% of shares redeemed, leaving it with $29.5 million in trust.

It achieved this result thanks in part to a non-redemption agreement and forward purchase agreement it signed earlier this week through which Meteora Capital Partners agreed to hold onto 9.5% of its equity through close. After expenses, Alpha Healthcare III expects Carmell to add $16.1 million to its balance sheet.

Some of that capital may be immediately put to work as the parties announced they had signed an LOI to acquire a commercial-stage biotech firm following close for $8 million in cash and $57 million in Carmell stock.

Alpha Healthcare III initially inked the $188 million merger with Carmell in January. Pittsburgh-based Carmell is developing a treatment platform to accelerate healing in bone fractures and soft tissue wounds.


  • Goodwin Procter LLP acted as legal counsel to Alpha Healthcare III.
  • Troutman Pepper Hamilton Sanders LLP acted as legal counsel to Carmell.
Recent Posts
by Marlena Haddad on 2023-12-08 at 1:59pm

Mobiv Acquisition Corp. (NASDAQ:MOBV) announced this afternoon that it has closed its combination with EV motorcycle-maker SRIVARU. Shareholders originally approved the deal at a special meeting held back on September 28, but at that time, the parties expected the transaction to take just a week to close. Redemptions whittled Mobiv’s IPO share pool of 10,005,000 down...

by Nicholas Alan Clayton on 2023-12-08 at 11:12am

Achari Ventures I (NASDAQ:AVHI) has entered into a definitive agreement to combine with medtech firm Vaso Corporation at an equity value of $176 million, or 19.5x its 2022 adjusted EBITDA. Wuxi, China-based Vaso provides IT services and sales support to medical device manufacturers. The combined company is expected to trade on the Nasdaq under the...

by Marlena Haddad on 2023-12-08 at 10:27am

EF Hutton Acquisition Corp. I (NASDAQ:EFHT) announced this morning that its shareholders have approved its business combination with E.C.D. Auto Design. At the meeting, there were 5,089,203 shares of common stock, representing approximately 76.82% of the issued and outstanding shares of common stock, present. In connection with the meeting, the company’s stockholders holding 3,470,945 shares,...

by Marlena Haddad on 2023-12-08 at 9:42am

Legato Merger Corp. III (NYSE:LEGT) filed for a $175 million IPO yesterday afternoon, becoming the fourth SPAC to file this week. While the other three SPACs that filed their S-1s earlier this week intend to pursue targets in the financial services and biotech industries, Legato III, similar to the earlier Legato SPACs, will focus on...

by Nicholas Alan Clayton on 2023-12-08 at 7:48am

At the SPAC of Dawn This week ends with an unusually busy earnings calendar as 172 US-listed companies report quarterly figures today. Among them is Exela Technologies (NASDSAQ:XELA), which completed a combination with Quinpario 2 in 2017. The billing software company has gone on to do another SPAC deal on November 29, this time spinning...


Copyright © 2023 SPACInsider, Inc. All Rights Reserved